Biomerica
Financial ratios & Valuation

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-21.42-8-22.72-23.79-8.66-27.59-6.73-9.78-2.71-1.63-4.52-8.66
Price/Sales ratio
1.432.333.566.263.989.646.042.353.631.801.569.64
Price/Book Value ratio
1.262.294.598.065.204.544.715.321.651.483.474.54
Price/Cash Flow ratio
-17.50-57.46-28.56-29.70-9.23-15.02-8.29-92.30-3.54-1.82-5.36-9.23
Price/Free Cash Flow ratio
-16.50-39.47-25.21-26.73-8.58-14.61-7.84-68.14-3.49-1.78-5.25-8.58
Price/Earnings Growth ratio
-0.46-0.020.50-0.43-0.162.39-0.040.29-0.060.05-0.13-0.16
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
31.06%29.65%34.90%31.53%24.84%26.62%6.90%15.77%8.35%11.28%16.11%26.62%
Operating Profit Margin
-13.51%-16.08%-16.48%-26.63%-46.39%-35.90%-90.60%-24.02%-135.28%-117.58%-34.82%-46.39%
Pretax Profit Margin
-13.02%-15.48%-15.68%-25.77%-45.54%-34.83%-89.67%-23.88%-132.77%-109.62%-34.48%-45.54%
Net Profit Margin
-6.67%-29.17%-15.68%-26.34%-46.01%-34.94%-89.85%-24.01%-133.73%-110.39%-34.57%-46.01%
Effective Tax Rate
48.73%-88.41%-5.13%-2.21%-1.02%-0.31%-0.20%-0.52%-0.71%-0.70%-0.27%-1.02%
Return on Assets
-5.41%-26.19%-18.10%-28.06%-45.62%-13.55%-54.73%-39.83%-49.39%-64.59%-56.13%-13.55%
Return On Equity
-5.91%-28.72%-20.23%-33.88%-60.11%-16.45%-70.10%-54.42%-60.90%-90.69%-66.11%-16.45%
Return on Capital Employed
-11.97%-15.84%-21.26%-34.25%-60.60%-15.22%-62.00%-48.42%-57.74%-90.31%-68.75%-15.22%
Liquidity Ratios
Current Ratio
8.529.557.964.993.559.997.09N/AN/AN/A4.593.55
Quick Ratio
4.655.874.692.571.858.064.633.485.522.423.351.85
Cash ratio
2.073.732.311.340.545.843.222.944.991.892.870.54
Days of Sales Outstanding
81.7568.8466.8052.47102.0996.3073.7714.9649.3563.8319.2996.30
Days of Inventory outstanding
216.33188.07167.41208.73200.87211.88174.6055.48153.37180.5255.77211.88
Operating Cycle
298.09256.91234.21261.21302.96308.19248.3770.44202.72244.3560.53308.19
Days of Payables Outstanding
38.0432.9032.5762.8193.3461.9423.4716.9025.6621.8818.1261.94
Cash Conversion Cycle
260.04224.01201.64198.40209.62246.24224.9053.54177.06222.4714.91246.24
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/A0.020.03N/AN/A0.26N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/A0.030.04N/AN/A0.36N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.11N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.030.03N/AN/A0.14N/A
Interest Coverage Ratio
N/A-4.95K-3.38K-40.04K-51.33K-266.98K-17.77KN/AN/AN/AN/A-51.33K
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/A-16.01-1.40N/AN/A-3.75N/A
Company Equity Multiplier
1.091.091.111.201.311.211.281.361.231.401.361.31
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.08-0.04-0.12-0.21-0.43-0.64-0.72-0.02-1.02-0.99-0.29-0.43
Free Cash Flow / Operating Cash Flow Ratio
1.061.451.131.111.071.021.051.351.011.021.021.02
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/A-16.01-1.40N/AN/A-3.75N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-16.01-1.40N/AN/A-13.50N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A